Simcere Pharmaceutical Group Limited

HKEX:2096.HK

6.21 (HKD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q1
Operating Activities:
Net Income -779.944-779.9441,137.3241,137.324433.542433.54231.89231.892474.641474.641278.907278.907242.008242.00892.75992.759271.308271.308230.504230.504384.08922.74429.943-20.822.1632.91735.27
Depreciation & Amortization 73.16573.16572.58972.58971.43771.43762.89462.89456.16356.16361.03261.03253.56853.56848.91748.91743.99143.99129.47629.4760000000
Deferred Income Tax 0000-13.773-13.42700305.157300.26200334.039321.03400219.968215.569-0.462-0.4750000000
Stock Based Compensation -20.797-20.79726.85726.85733.14933.14935.99735.99728.03228.0323.1643.1647.5367.5368.8638.8635.8275.8271.2491.2498.98.59.89.9373.93.2954.682
Change In Working Capital -468.257-468.2570046.95346.95300-426.63-426.6300-277.786-277.78600-160.136-160.13649.61349.6130000000
Accounts Receivables -161.449-161.4490043.12243.12200-272.601-272.60100-271.076-271.07600-189.137-189.137-4.06-4.060000000
Change In Inventory -188.32-188.3200-58.496-58.49600-4.165-4.16500-17.731-17.73100-13.243-13.2433.2183.2180000000
Change In Accounts Payables 000000000000000000000000000
Other Working Capital -118.488-118.4880062.32762.32700-149.864-149.8640011.0211.020042.24442.24450.45550.4550000000
Other Non Cash Items 1,312.3731,312.373-1,277.786-1,277.786-250.53-250.53211.717211.71728.22528.225-604.519-604.519136.869136.869-264.367-264.367-101.764-101.76416.33516.335-392.989-31.244-39.74320.8-22.16-36.211-39.952
Operating Cash Flow 116.541116.541-41.017-41.017334.55334.55342.5342.5160.431160.431-261.416-261.416162.195162.195-113.829-113.82959.22659.226327.176327.17611.27610.73312.23912.3564.813.2954.682
Investing Activities:
Investments In Property Plant And Equipment -241.591-241.59100-171.408-171.40800-104.744-104.74400-176.421-176.42100-131.013-131.013-122.816-122.8160000000
Acquisitions Net 0000000000000.880.880000000000000
Purchases Of Investments 000000000000000000000000000
Sales Maturities Of Investments 000000000000000000000000000
Other Investing Activites 109.443109.443676.052676.052-43.72-43.72249.28249.28197.712197.712-310.72-310.72191.996191.996248.087248.087-64.974-64.97422.33922.3390000000
Investing Cash Flow -132.149-132.149676.052676.052-215.127-215.127249.28249.2892.96892.968-310.72-310.7216.45516.455248.087248.087-195.987-195.987-100.477-100.4770000000
Financing Activities:
Debt Repayment 000000000000000000000000000
Common Stock Issued 000000000000000000000000000
Common Stock Repurchased -120.021-120.021-24.516-24.51600000000000000-0.2-0.20000000
Dividends Paid -209.609-209.60900-195.648-195.64800-195.648-195.64800000000-456.027-456.0270000000
Other Financing Activities 124.395124.395-217.667-217.667-34.47-34.47-146.723-146.723-200.116-200.116-416.502-416.5021,190.2141,190.214-13.403-13.4038.0568.056-58.304-58.3040000000
Financing Cash Flow -205.235-205.235-242.182-242.182-230.118-230.118-146.723-146.723-395.764-395.764-416.502-416.5021,190.2141,190.214-13.403-13.4038.0568.056-514.531-514.5310000000
Other Information:
Effect Of Forex Changes On Cash 0.9210.9211.4941.4946.6716.6710.8920.892-13.364-13.364-4.186-4.186-31.701-31.701-0.299-0.2990.2390.239-0.123-0.1230000000
Net Change In Cash -219.923-219.923394.348394.348-103.718-1,979.467445.948445.948-155.72972.075-1,453.882-992.8231,337.1621,583.97674.469120.556-128.467-56.724-411.748-287.95511.27610.73312.23912.3564.813.2954.682
Cash At End Of Period -219.923-219.923394.348394.348-117.381-114.4321,865.035550.931-191.0541,356.6711,284.596-1,177.8881,588.0272,179.892595.916131.963-143.771555.013611.737-336.79511.27610.73312.23912.3564.813.2954.682